Condition: Leukemia, Myeloid, Acute · Leukemia, Lymphocytic, Chronic, B-Cell · Lymphoma, Non-Hodgkin · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to collect long-term safety data in participants with cancers including acute myeloid leukemia, non-Hodgkin lymphoma, myelodysplastic syndrome, chronic lymphocytic leukemia (type of cancer of the blood and bone marrow in which the bone marrow makes a large number of abnormal blood cells) and advanced solid tumors and metastatic castration-resistant prostate cancer (mCRPC).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Macquarie University Hospital | Macquarie University, Australia | — |
| Linear Clinical Research Ltd | Nedlands, Australia | — |
| Scientia Clinical Research | Randwick, Australia | — |
| Ghent University Hospital | Ghent, Belgium | — |
| Hopital Claude Huriez | Lille, France | — |
| CHU Nantes | Nantes, France | — |
| Institut Gustave Roussy | Villejuif, France | — |
| Arensia Exploratory Medicine | Tbilisi, Georgia | — |
| Alexandra Hospital | Athens, Greece | — |
| Rambam Med.Center - Hematology Institute | Haifa, Israel | — |
| Rambam Medical Center | Haifa, Israel | — |
| Carmel Medical Center | Haifa, Israel | — |
+ 24 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.